(+)-S-20499 - A potential antidepressant? A behavioural and neurochemical investigation in the olfactory bulbectomised rat

European Neuropsychopharmacology

Volumn 9, Issue 1-2, 1999, Pages 21-27

  McGrath, C ^a,b   Norman, T R ^a  

^a AUSTIN HEALTH   (Australia)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

1 receptor; (+) S 20499; 5 HT2; Olfactory bulbectomy; Receptor binding

Indexed keywords

ALNESPIRONE; ANTIDEPRESSANT AGENT; BETA 1 ADRENERGIC RECEPTOR; SEROTONIN 1A AGONIST; SEROTONIN 2 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; LONG TERM CARE; MALE; MAZE TEST; NEUROCHEMISTRY; NONHUMAN; OLFACTORY BULBECTOMY; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; RECEPTOR DENSITY; SCREENING TEST;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ANTIDEPRESSIVE AGENTS; ANXIETY; BEHAVIOR, ANIMAL; BODY TEMPERATURE; BRAIN CHEMISTRY; MALE; NERVE TISSUE PROTEINS; OLFACTORY BULB; PROPANOLAMINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS; SPIRO COMPOUNDS;

EID: 0033005043     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(97)00103-X     Document Type: Article

References (41)

1. Banerjee, S.P., Kung, L.S., Riggi, S.J., Chanda, S.K., 1977. Development of β-adrenergic subsensitivity by antidepressants. Nature 268, 455-456.
2. 1A agonist, (+) S-20244 and its enantiomers (+) S-20499 and (-) S-20500. Psychopharmacology 116, 73-78.
3. 2 receptor binding on blood platelets - a peripheral marker for depression? Life Sci. 41, 2485-2492.
4. Blier, P., De Montigny, C., Chaput, Y., 1987. Modification of the serotonergic system by antidepressant treatments: implications for the therapeutic response in major depression. J. Clin. Psychopharmacol. 7, 24S-35S.
5. Butler, J., Tannian, M., Leonard, B.E., 1988. The chronic effects of desipramine and sertraline on platelet and synaptosomal 5-HT uptake in olfactory bulbectomised rats. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 12, 585-594.
6. Cairncross, K.D., Wren, A.F., Cox, B., Shnieden, H., 1977. Effects of olfactory bulbectomy and domicile on stress induced corticosterone release in the rat. Physiol. Behav. 19, 405-417.
7. 1A receptor agonist. Eur. J. Pharmacol. 144, 223-229.
8. 1A agonist flesinoxan in three paradigms for assessing antidepressant potential in the rat. Eur. Neuropsychopharmacol. 7, 109-114.
9. 1A full agonist in the elevated plus-maze and social interaction tests. Drug Dev. Res. 32, 183-190.
10. De Montigny, C., 1984. Electroconvulsive treatments enhance responsiveness of forebrain neurons to serotonin. J. Pharmacol. Exp. Ther. 228, 230-234.
11. De Montigny, C., Aghajanian, C.K., 1978. Tricyclic antidepressants: long term treatment increases responsivity of rat forebrain neurons to serotonin. Science 202, 1303-1306.
12. B receptors in the frontal cortex of olfactory bulbectomised rats. Eur. J. Pharmacol. 262, 143-148.
13. 2 receptors in olfactory bulbectomised (OB) rats after chronic treatment with mianserin and desipramine. Hum. Psychopharmacol. 9, 397-407.
14. 1A mediated responses: effect of treatment that modify serotonergic transmission. Ann. New York Acad. Sci. 600, 460-474.
15. Glassman, A., 1969. Indoleamines and affective disorder. Psychosom. Med. 31, 107-114.
16. 2 receptor-mediated head-twitch behaviour following antidepressant treatment to mice. Br. J. Pharmacol. 83, 235-242.
17. Gray, J.A., Lalljee, B., 1974. Sex differences in emotional behaviour in the rat: correlation between open field defecation and active avoidance. Anim. Behav. 22, 856-861.
18. 1A receptor agonist, in treatment resistant depression. Int. Clin. Psychopharmacol. 8, 167-172.
19. 1A Receptors. Ellis Horwood, Chichester, pp. 34-51.
20. Janscar, S., Leonard, B.E., 1983. The olfactory bulbectomised rat as an animal model of depression. In: Usdin, E., Goldstein, M., Friedhoff, A.J., Georgotas, A. (Eds.), Frontiers in Neuropsychiatrie Research. Macmillan, New York, pp. 357-372.
21. 1A agonists and conventional antidepressants in an animal model of depression. Eur. J. Pharmacol. 134, 265-274.
22. 1A receptors. J. Pharmacol. Exp. Therap. 264, 863-872.
23. Lloyd, K.G., Garrigou, D., Broekkamp, C.L.E., 1982. The action of monoaminergic, cholinergic and GABAergic compounds in the olfactory bulb rat model of depression. In: Langer, S.Z., Takahashi, R., Segawas, T., Briley, M. (Eds.), New Vistas in Depression. Pergamon Press, Elmsford, New York, pp. 179-186.
24. Lowry, O.H., Roseborough, N.J., Farr, A.L., Randall, R.J., 1951. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193, 265-275.
25. 1A agonist in the learned helplessness paradigm in rats. Psychopharmacology 104, 275-278.
26. 1A receptor agonist, in the learned helplessness paradigm: evidence for a postsynaptic mechanism. Behav. Brain Res. 38, 135-144.
27. McGrath, C., 1996. The olfactory bulbectomised rat model of depression: biochemical, neurochemical and pharmacological studies. Ph.D. Thesis, National University of Ireland.
28. McNamara, M.G., Kelly, J.P., Leonard, B.E., 1995. Effect of 8-OH-DPAT in the olfactory bulbectomised model of depression. J. Ser. Res. 2, 91-99.
29. McPherson, G.A., 1985. Analysis of radioligand binding experiments: a collection of computer programs for the IBM PC. J. Pharmacol. Methods 14, 213-228.
30. O'Connor, W.T., Leonard, B.E., 1988. Behavioural and neuropharmacological properties of the dibenzazepines, desipramine and lofepramine: studies on the olfactory bulbectomised rat model of depression. Prog. Neuro-Pharmacol. Biol. Psychiat. 12, 45S-56S.
31. Ordway, G.A., Gambarana, C., Frazer, A., 1988. Quantitative autoradiography of central β-adrenoceptor subtypes: comparison of the effects of chronic treatment with desipramine or centrally administered 1-isoprenaline. J. Pharmacol. Exp. Ther. 247, 379-389.
32. 1A Receptors. Ellis Horwood, Chichester, p. 67.
33. Pellow, S., Chopin, P., File, S.E., Briley, M., 1985. Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods 14, 149-167.
34. 1A agonist properties: S-20499. Drug. Develop. Res. 27, 389-402.
35. 1A agonists. J. Pharmacol. Exp. Ther. 270, 198-208.
36. Song, C., Leonard, B.E., 1994. Serotonin reuptake inhibitors reverse the impairments in behaviour, neurotransmitter and immune functions in the olfactory bulbectomised rat. Hum. Psychopharmacol. 9, 135-146.
37. Sulser, F., Vetulani, J., Mobley, P.L., 1978. Mode of action of antidepressant drugs. Biochem. Pharmacol. 27, 257-261.
38. Tiong, A.H.K., Richardson, J.S., 1990. Differential effects of olfactory bulbectomy on β-adrenoceptors in rat amygdala, hippocampus and cerebral cortex. Brain Res. 531, 269-275.
39. Van Reizen, H., Leonard, B.E., 1990. Effects of psychotropic drugs on the behaviour and neurochemistry of olfactory bulbectomised rats. In: File, S.E. (Ed.), Psychopharmacology of Anxiolytics and Antidepressants. Pergamon Press, Elmsford, New York pp. 231-250.
40. 1 receptor subtypes in the brain of vehicle or 5, 7-dihydroxy-tryptamine treated rats. J. Neurosci. 6, 3474-3482.
41. Vetulani, J., Stawarz, R.J., Dingell, J.V., Sulser, F., 1976. A possible common mechanism of action of antidepressant treatments. Naunyn-Schmiedebergs Arch. Pharmacol. 293, 109-114.